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Abstract. A series of 4-aryl-N-(4-pheny-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides
were synthesized by condensing 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid with 2-amino-
4-aryl-thiazole derivatives. The newly synthesized molecules were characterized by spectral analysis and
subjected to antioxidant and DNA damage inhibition studies.
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1. Introduction
Oxadiazines are interesting and promising six-
membered heterocyclic compounds with oxygen and
nitrogen atoms. 1,3,4-oxadiazine derivatives exhibit
biological activities such as cardiovascular, antibacte-
rial, plant growth regulating, miticidal and nematocidal,
acricidal, insecticidal and anticonvulsive activities.1
In addition, oxadiazine derivatives are also used as
drugs for the treatment of anaemia2 and viral diseases.3
Thiazoles are important class of natural and synthetic
compounds and display a wide range of biological
activities such as cardiotonic,4 sedative,5 anaesthetic,6
bactericidal7 and anti-inflammatory.8
The main characteristic of an antioxidant is its ability
to trap free radicals. Highly reactive free radicals or
reactive oxygen species (ROS) are present in biologi-
cal systems from a wide variety of sources.9 These free
radicals can cause a number of chain reactions and may
oxidize nucleic acids, proteins, lipids or DNA and can
initiate several diseases.10 Antioxidants terminate these
chain reactions by removing free radical intermediates
and inhibit other oxidation reactions, thus inhibiting
the oxidative mechanism that leads to degenerative
diseases. They do this by oxidizing themselves, so
antioxidants are often reducing agents. Antioxidants are
widely used as dietary supplements and are being inves-
tigated for the prevention of diseases such as cancer,
coronary heart disease and even altitude sickness.11
DNA damage can lead to mutation if replication pro-
ceeds without proper repair. Oxidative stress-induced
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DNA damage by the reactive oxygen species and chem-
ical carcinogens can lead to mutations and is suspected
to be a major cause of cancer.12 In order to protect
the genome from deleterious effects of ROS, cells have
antioxidants, ROS-eliminating enzymes and efficient
DNA repair pathways. Among DNA damage causing
cancer development, approximately 80% of the damage
is caused by ROS such as hydrogen peroxide (H2O2),
singlet oxygen (1O2) and hydroxyl radical (•OH). There-
fore, protection of oxidative DNA damage induced by
ROS is very important for cancer prevention.13
Benzoxadiazines derived from embelin (herbs
extract) is reported to exhibit antioxidant and free radi-
cal scavenging activities.14 Various oxadiazines linked
with other heterocyclic moieties show enhanced bio-
logical activities.15–17 In addition, oxadiazines bearing
thiazole moiety exhibit antifungal activities.18
In order to achieve promising antioxidants, we have
synthesized a new series of 4-aryl-N-(4-aryl-thiazol-2-
yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides
(7a–l) by condensing 4-aryl-5,6-dihydro-4H-1,3,4-
oxadiazine-2-carboxylic acid (6a–d) with 2-amino-
4-aryl-thiazole derivatives (2a–d) as illustrated in
schemes 1 and 2.
2. Experimental
The melting points were measured with micro mel-
ting point apparatus and are uncorrected. All chemi-
cals/reagents used were purchased from Merck Chem-
icals (India), Fluka Chemicals (India) and IR spec-
tra were recorded in KBr pellets on Shimadzu 8300
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Scheme 1. Synthesis of 2-amino-4-aryl-thiazole.
Scheme 2. Synthesis of 4-aryl-5,6-dihydro-4H-1,3,4- 51 oxadiazine-2-carboxylic acid.
Scheme 3. Synthesis of 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4h-1,3,4-oxadiazine-2-carboxamides.
spectrometer. The 1H NMR spectra were recorded
on a Bruker supercon 400 MHz spectrophotometer
using DMSO-d6 as solvent and Tetra methyl silane
(TMS) as an internal standard. The chemical shifts
were expressed in ppm. Mass spectra were obtained
on LC-MSD-Trap-XCT-Plus spectrophotometer. Thin
layer chromatography (TLC) was performed on
pre-coated Silica Gel sheet (HF 254, Sd-fine) and
visualization of the spots was done in iodine vapour
and UV light. Chromatographic separations were car-
ried out on silica gel (60-120) mesh using petroleum
ether: acetone (9:1) as eluent (scheme 3).
2.1 General procedure for the synthesis
of 2-amino-4-aryl-thiazole 2a-d
2-amino-4-aryl thiazole derivatives were prepared19–21
using different substituted phenacyl bromides by
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refluxing with excess thiourea in presence of conc. HCl
for about 20 min. After the completion of reaction, the
reaction mixture was cooled to room temperature; the
pale yellow solid thus separated was filtered, washed
with chloroform, dried and recrystallized from ethanol
to obtain 2-amino-4-aryl thiazole derivatives.
2.2 Typical procedure for the synthesis of 4-phenyl-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid:
(6a)
An oven-dried two-neck round bottom flask was
charged with a solution of 4-phenyl-5,6-dihydro-
4H-1,3,4-oxadiazine-2-carboxylate22 –24 (5a, 2.35 g,
10.00 mmol) in 25 mL of methanol. A volume of 10 mL
of 5% NaOH solution was added dropwise to the reac-
tion mixture and allowed to stir at room temperature for
24 h. After completion of reaction (monitored by TLC),
methanol was evaporated under reduced pressure and
the residue was acidified with dil. HCl. The white solid
thus separated was filtered, dried and recrystallized
from 20 mL ethanol to obtain 4-phenyl-5,6-dihydro-
4H-1,3,4-oxadiazine-2-carboxylic acid (6a, 1.64 g)
80% yield; IR (KBr cm−1): ν 3061 (Ar-CH), 1133
(C-O-C), 1680 (>C=O), 2737 (-OH), 1256 (C-O),
1579 (Ar-C=C); 1H NMR (DMSO-d6): δ 3.81 (t, 2H,
J = 5.2 Hz), 4.43 (t, 2H, J = 5.6 Hz), 6.95–7.42
(m, 5H), 11.82 (s, 1H); 13C NMR (DMSO-d6): δ 54.2
(C-6), 63.1 (C-5), 113.8 (C-9 and C-13), 121.3
(C-11), 129.8 (C-10 and C-12), 144.1 (C-8), 150.9 (C-
2), 168.1 (C-7). LC-MS: 207.0 (M+H)+. Anal. %
Calcd for C10H10N2O3: C: 58.51, H: 4.97, N: 13.36;
Found; C: 58.25, H: 4.89, N: 13.45. Same procedure
was followed for all the derivatives.
2.2a 4-(4-Chlorophenyl)-5,6-dihydro-4H-1,3,4-
oxadiazine-2-carboxylic acid (6b): Obtained from
5b (2.70 g, 10.00 mmol), yield 82% (1.98 g); IR
(KBr cm−1): ν 2350 (Ar-Cl), 3063 (Ar-CH), 1130
(C-O-C), 1685 (>C=O), 2734 (-OH), 1242 (C-O),
1578 (Ar-C=C); 1H NMR (DMSO-d6): δ 3.81 (t, 2H,
J = 5.2 Hz), 4.43 (t, 2H, J = 5.6 Hz), 7.16–7.44 (m,
4H), 11.78 (s, 1H); 13C NMR (DMSO-d6): δ 54.2
(C-6), 63.0 (C-5), 116.2 (C-9 and C-13), 126.4 (C-11),
129.9 (C-10 and C-12), 141.9 (C-8), 150.9 (C-2), 168.1
(C-7); LC-MS: 242.6 (M+H)+. Anal. % Calcd for
C10H9ClN2O3: C: 50.02, H: 4.89, N: 11.73. Found: C:
49.91, H: 4.72, N: 11.64.
2.2b 4-(4-Methoxyphenyl)-5,6-dihydro-4H-1,3,4-
oxadiazine-2-carboxylic acid (6c): Obtained from 5c
(2.64 g, 10.00 mmol), yield 81% (1.91 g); IR (KBr
cm−1): ν 2845 (-OCH3), 1683 (>C=O), 2735 (-OH),
1242 (C-O), 3061 (Ar-CH), 1132 (C-O-C), 1580
(Ar-C=C); 1H NMR (DMSO-d6): δ 3.82 (t, 2H, J =
5.2 Hz), 3.90 (s, 3H, -OCH3) 4.43 (t, 2H, J = 5.6 Hz),
6.64–7.11 (m, 4H), 11.8 (s, 1H); 13C NMR (DMSO-
d6): δ 54.2 (C-6), 55.9 (-OCH3), 63.1 (C-5), 114.8
(C-9 and C-13), 115.3 (C-10 and C-12), 136.4 (C-8),
152.4 (C-11), 150.8 (C-2), 168.1 (C-7); LC-MS: 237.3
(M+H)+; Anal. % Calcd for C11H12N2O4: C: 55.95,
H: 5.12, N: 11.86. Found: C: 55.91, H: 5.05, N: 11.74.
2.2c 4-(4-Nitrophenyl)-5,6-dihydro-4H-1,3,4-
oxadiazine-2-carboxylic acid (6d): Obtained from 5d
(2.80 g, 10.00 mmol), yield 85% (2.14 g); IR (KBr
cm−1): ν 1545 and 1350 (-NO2), 1695 (>C=O), 2742
(-OH), 1248 (C-O), 3071 (Ar-CH), 1142 (C-O-C),
1582 (Ar-C=C); 1H NMR (DMSO-d6): δ 3.82 (t, 2H,
J = 5.2 Hz), 4.42 (t, 2H, J = 5.6 Hz), 7.32–8.24 (m,
4H), 11.8 (s, 1H); 13C NMR (DMSO-d6): δ 54.3 (C-6),
63.1 (C-5), 114.7 (C-9 and C-13), 124.9 (C-10 and
C-12), 141.3 (C-11), 150.1 (C-8), 150.9 (C-2), 168.1
(C-7); LC-MS: 252.3 (M+H)+; Anal. % Calcd for
C10H9N3O5: C: 47.77, H: 3.57, N: 16.78. Found: C:
47.88, H: 3.61, N: 16. 63.
2.3 Typical procedure for the synthesis
of 4-phenyl-N-(4-phenyl-thiazol-2-yl)-5,6-dihydro-4H-
1,3,4-oxadiazine-2-carboxamides (7a)
4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carbo-
xylic acid (6a, 2.30 g, 11.00 mmol) was taken in round
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bottomed flask and dissolved in 30 mL of CHCl3, after
10 min, HOBt (2.00 g, 15.00 mmol) and 1-ethyl-3-(3-
dimethylaminopropyl) carbodimide (EDC.HCl) (2.81 g,
15.00 mmol) were added. The reaction mixture was
stirred at room temperature for 15 min, then 2-amino-4-
phenyl thiazole (2a, 1.76 g, 10.00 mmol) and 1.15 mL
(11.00 mmol) of triethylamine were added and stirred
at room temperature for about 5–6 h. After completion
of reaction (monitored by TLC), the reaction mixture
was extracted with CHCl3 (3 × 20 mL). The combined
organic layer was washed with 5% NaHCO3 solution
followed by 5% HCl solution and finally with distilled
water and then dried over anhydrous Na2SO4. The
CHCl3 layer was evaporated under reduced pressure;
the crude solid thus obtained was purified by column
chromatography using petroleum ether: acetone (8:2) as
eluent, which afforded 4-phenyl-N-(4-phenyl-thiazol-
2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide
(7a, 2.05 g) as pale yellow solid in 55% yield, mp
126–128◦C. IR (KBr cm−1): ν 3114.70 (-NH), 1680
(>C=O), 3059.1 (Ar-CH), 1133 (C–O–C), 1579 (Ar-
C=C), 719 (C–S); 1H NMR (DMSO-d6): δ 3.81 (t, 2H,
J = 5.2 Hz), 4.42 (t, 2H, J = 5.6 Hz), 6.95–7.42 (m,
5H), 7.52–7.95 (m, 5H), 7.68 (s, 1H) 12.26 (s, 1H); 13C
NMR (DMSO-d6): δ 53.9 (C-6), 62.9 (C-5), 105.8 (C-5′),
113.7 (C-13 and C-9), 121.3 (C-11), 129.7 (C-12 and
C-10), 144.1 (C-8), 127.8 (C-8′ and C-12′), 128.9 (C-
10′), 129.5 (C-9′ and C-11′), 133.3 (C-7′), 150.4 (C-4′),
150.9 (C-2), 161.2 (C-7), 164.5 (C-2′); LC-MS: 365.2
(M+H)+. Anal. % Calcd for C19H16N4O2S: C: 62.66,
H: 4.43, N: 15.45. Found: C: 62.60, H: 4.39, N: 15.37.
Same procedure was followed for all the derivatives.
2.3a 4-Phenyl-N-(4-(4-chlorophenyl)-thiazol-2-yl)-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7b):
Obtained from 6a (2.30 g, 11.00 mmol) and 2b (2.10 g,
10.00 mmol), yield 58% (2.32 g); IR (KBr cm−1): ν
3112 (-NH), 1686 (-C=O), 3061 (Ar-CH), 1130 (C-
O-C), 1582 (Ar-C=C), 720 (C-S), 2350 (Ar-Cl); 1H
NMR (DMSO-d6): δ 3.81 (t, 2H, J = 5.2 Hz), 4.42
(t, 2H, J = 5.6 Hz), 6.93–7.41 (m, 5H), 7.66–8.14 (m,
4H), 7.66 (s, 1H) 12.26 (s, 1H); 13C NMR (DMSO-d6):
δ 53.9 (C-6), 62.8 (C-5), 105.8 (C-5′), 113.9 (C-9 and
C-13), 121.3 (C-11), 129.8 (C-10 and C-12), 144.2
(C-8), 129.0 (C-8′ and C-12′), 129.9 (C-9′ and C-11′),
135.1 (C-10′), 131.32 (C-7′), 150.5 (C-4′), 150.9 (C-2),
161.2 (C-7), 164.5 (C-2′); LC-MS: 400.1 (M+H)+.
Anal. % Calcd for C19H15N4ClO2S: C: 57.21, H: 3.94,
N: 14.15; Found: C: 57.17, H: 3.81, N: 14.04.
2.3b 4-Phenyl-N-(4-(4-hydroxyphenyl)-thiazol-2-yl)-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7c):
Obtained from 6a (2.30 g, 11.00 mmol) and 2c (1.92 g,
10.00 mmol), yield 56% (2.13 g); IR (KBr cm−1): ν
3113 (-NH), 1684 (-C=O), 3058 (Ar-CH), 1135 (C-
O-C), 1576 (Ar-C=C), 722 (C-S), 3650 (Ar-OH); 1H
NMR (DMSO-d6): δ 3.81 (t, 2H, J = 5.2 Hz), 4.43
(t, 2H, J = 5.6 Hz), 6.91–7.44 (m, 5H), 6.94–7.62 (m,
4H), 5.42 (s, 1H), 7.64 (s, 1H), 12.26 (s, 1H); 13C NMR
(DMSO-d6): δ 53.9 (C-6), 62.8 (C-5), 105.8 (C-5′),
113.8 (C-9 and (C-13), 121.3 (C-11), 129.8 (C-10 and
C-12), 144.2 (C-8), 129.1 (C-8′ and C-12′), 117.8 (C-9′
and C-11′), 155.8 (C-10′), 126.3 (C-7′), 150.5 (C-4′),
150.9 (C-2), 161.2 (C-7), 164.6 (C-2′). LC-MS: 381.4
(M+H)+; Anal. % Calcd for C19H16N4O3S: C: 60.12,
H: 4.24, N: 14.73; Found: 59.99, H: 4.20, N: 14.75.
2.3c 4-Phenyl-N-(4-p-tolyl)-thiazol-2-yl)-5,6-dihydro-
H-1,3,4-oxadiazine-2-carboxamide (7d): Obtained
from 6a (2.30 g, 11.00 mmol) and 2d (1.90 g
10.00 mmol) yield 57% (2.16 g); IR (KBr cm−1): ν
3115 (-NH), 1682 (-C=O), 3061 (Ar-CH), 1131 (C-O-
C), 1581 (Ar-C=C), 716 (C-S); 1H NMR (DMSO-d6):
δ 2.33 (s, 3H), 3.80 (t, 2H, J = 5.2 Hz), 4.43 (t, 2H,
J = 5.6 Hz), 6.95–7.42 (m, 5H), 7.40–7.82 (m, 4H),
7.60 (s, 1H) 12.26 (s, 1H); 13C NMR (DMSO-d6):
δ 21.5 (-CH3), 53.9 (C-6), 62.8 (C-5), 105.8 (C-5’),
113.9 (C-9 and C-13), 121.3 (C-11), 129.8 (C-10 and
C-12), 144.2 (C-8), 127.6 (C-8′ and C-12′), 129.9 (C-9′
and C-11′), 137.8 (C-10′), 130.4 (C-7′), 150.4 (C-4′),
150.9 (C-2), 161.2 (C-7), 164.5 (C-2′); LC-MS: 379.1
(M+H)+; Anal. % Calcd for C20H18N4O2S: C: 63.51,
H: 4.79, N: 14.83; Found: C: 63.47, H: 4.76, N: 14.80.
2.3d 4-(4-Chlorophenyl)-N-(4-(4-chlorophenyl)-thiazol-
2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide
(7e): Obtained from 6b (2.62 g, 11.00 mmol) and 2b
(2.10 g, 10.00 mmol) yield 56.5% (2.45 g); IR (KBr
cm−1): ν 3112 (-NH), 1690 (-C=O), 3055 (Ar-CH),
1135 (C-O-C), 1575 (Ar- C=C), 715 (C-S), 2350 (Ar-
Cl); 1H NMR (DMSO-d6): δ 3.81(t, 2H, J = 5.2 Hz),
4.43 (t, 2H, J = 5.6 Hz), 6.55–7.40 (m, 4H), 7.66–8.14
(m, 4H), 7.67 (s, 1H) 12.26 (s, 1H); 13C NMR (DMSO-
d6): δ 53.9 (C-6), 62.9 (C-5), 105.8 (C-5′), 116.2 (C-9
and C-13), 126.4 (C-11), 129.9 (C-10 and C-12), 141.9
(C-8), 129.0 (C-8′ and C-12′), 129.9 (C-9′ and C-11′),
135.1 (C-10′), 131.3 (C-7′), 150.5 (C-4′), 150.9 (C-2),
161.2 (C-7), 164.5 (C-2′). LC-MS: 434.3 (M+H)+;
Anal. % Calc for C19H14Cl2N4O2S: C: 52.67, H: 3.26,
N: 12.93; Found: C: 52.59, H: 3.20, N: 12.89.
2.3e 4-(4-Chlorophenyl)-N-(4-(4-hydroxyphenyl)-
thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-car-
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boxamide (7f): Obtained from 6b (2.62 g,
11.00 mmol) and 2c (1.92 g, 10.00 mmol), yield 58%
(2.40 g); IR (KBr cm−1): ν 3114 (-NH), 1690 (-C=O),
3058 (Ar-CH), 1136 (C-O-C), 1578 (Ar-C=C), 722
(C-S); 1H NMR (DMSO-d6): δ 3.81 (t, 2H, J =
5.2 Hz), 4.42 (t, 2H, J = 5.6 Hz), 6.55–7.39 (m, 4H),
6.97–7.65 (m, 4H), 5.43 (s, 1H), 7.66 (s, 1H) 12.26 (s,
1H); 13C NMR (DMSO-d6): δ 54.0 (C-6), 62.9 (C-5),
105.8 (C-5′), 116.3 (C-9 and C-13), 126.4 (C-11),
129.9 (C-10 and C-12), 142.0 (C-8), 129.1 (C-8′ and
C-12′), 117.8 (C-9′ and C-11′), 155.8 (C-10′), 126.3
(C-7′), 150.5 (C-4′), 150.9 (C-2), 161.2 (C-7), 164.5
(C-2′); LC-MS: 415.1 (M+H)+; Anal. % Calc for
C19H15ClN4O3S: C: 55.10, H: 3.64, N: 13.55; Found:
C: 55.01, H: 3.56, N: 13.50.
2.3f 4-(4-Chlorophenyl)-N-(4-(p-tolyl)-thiazol-2-yl)-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7g):
Obtained from 6b (2.62 g, 11.00 mmol) and 2d (1.90 g
10.00 mmol), yield 60% (2.48 g); IR (KBr cm−1): ν
3112 (-NH), 1688 (-C=O), 3061 (Ar-CH), 1136 (C-
O-C), 1583 (Ar- C=C), 722 (C-S), 2230 (Ar-C), 2350
(Ar-Cl); 1H NMR (DMSO-d6): δ 2.34 (s, 3H), 3.80
(t, 2H, J = 5.2 Hz), 4.42 (t, 2H, J = 5.6 Hz), 6.55–
7.39 (m, 4H), 7.40–7.82 (m, 4H), 7.68 (s,1H), 12.26
(s, 1H); 13C NMR (DMSO-d6): δ 21.5 (-CH3), 53.9
(C-6), 62.9 (C-5), 105.8 (C-5′), 116.2 (C-9 and C-13),
126.4 (C-11), 129.9 (C-10 and C-12), 141.9 (C-8),
127.6 (C-8′ and C-12′), 129.9 (C-9′ and C-11′), 137.8
(C-10′), 130.4 (C-7′), 150.4 (C-4′), 150.9 (C-2), 161.3
(C-7), 164.5 (C-2′); LC-MS: 413.1 (M+H)+; Anal. %
Calc for C20H17ClN4O2S: C: 55.10, H: 3.64, N: 13.55.
Found: C: 55.01, H: 3.56, N: 13.50.
2.3g 4-(4-Methoxyphenyl)-N-(4-(4-chlorophenyl)-
thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-car-
boxamide (7h): Obtained from 6c (2.68 g,
11.00 mmol) and 2b (2.10 g, 10.00 mmol) yield 59%
(2.52 g); IR (KBr cm−1): ν 3114 (-NH), 1680 (-C=O),
3059 (Ar-CH), 1133 (C-O-C), 1579 (Ar-C=C), 719
(C-S), 2350 (Ar-Cl); 1H NMR (DMSO-d6): δ 3.81
(t, 2H, J = 5.2 Hz), 3.90 (s, 3H, -OCH3), 4.43 (t, 2H,
J = 5.6 Hz), 6.55–7.39 (m, 4H), 7.16–7.71 (m, 4H),
7.65 (s, 1H) 12.26 (s, 1H); 13C NMR (DMSO-d6): δ
54.1 (C-6), 55.9 (-OCH3), 63.1 (C-5), 105.9 (C-5′),
114.8 (C-9 and C-13), 115.3 (C-10 and C-12), 129.1
(C-8′ and C-12′), 130.0 (C-9′ and C-11′), 131.3 (C-7′),
135.1 (C-10′), 136.4 (C-8), 150.5 (C-4′), 150.9 (C-2),
152.4 (C-11), 161.6 (C-7), 165.3 (C-2′); LC-MS: 428.6
(M+H)+; Anal. % Calc for C20H17ClN4O3S: C: 56.11,
H: 4.00, N: 13.16; Found: C: 56.01, H: 3.87, N: 13.06.
2.3h 4-(4-Methoxyphenyl)-N-(4-(4-hydroxyphenyl)-
thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-car-
boxamide (7i): Obtained from 6c (2.68 g,
11.00 mmol) and 2c (1.92 g, 10.00 mmol), yield 59.5%
(2.44 g) IR (KBr cm−1): ν 3113 (-NH), 1686 (-C=O),
3063 (Ar-CH), 1132 (C-O-C), 1584 (Ar-C=C), 723
(C-S), 3650 (Ar-OH); 1H NMR (DMSO-d6): δ 3.81
(t, 2H, J = 5.2 Hz), 3.88 (s, 3H, -OCH3), 4.43 (t, 2H,
J = 5.6 Hz), 6.64–7.10 (m, 4H), 6.97–7.65 (m, 4H),
5.47 (s, 1H), 7.67 (s, 1H) 12.26 (s, 1H); 13C NMR
(DMSO-d6): δ 54.1 (C-6), 55.9 (-OCH3), 63.1(C-5),
105.8 (C-5′), 114.8 (C-9 and C-13), 115.3 (C-10 and
C-12), 117.8 (C-9′ and C-11′), 129.1 (C-8′ and C-
12′), 155.8 (C-10′), 126.3 (C-7′), 136.4 (C-8), 150.5
(C-4′), 150.9 (C-2), 152.4 (C-11), 161.2 (C-7), 164.5
(C-2′); LC-MS: 411.1 (M+H)+; Anal. % Calc for
C20H18N4O4S: C: 58.58, H: 4.42, N: 13.65; Found: C:
58.53, H: 4.38, N: 13.61.
2.3i 4-(4-Methoxyphenyl)-N-(4-(p-tolyl)-thiazol-2-
yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide
(7j): Obtained from 6c (2.68 g, 11.00 mmol) and 2d
(1.90 g 10.00 mmol), yield 59% (2.40 g); IR (KBr
cm−1): ν 3116 (-NH), 1695 (-C=O), 3062 (Ar-CH),
1137 (C-O-C), 1582 (Ar-C=C), 722 (C-S), 3654 (Ar-
C); 1H NMR (DMSO-d6) : δ 2.35 (s, 3H, CH3), 3.81
(t, 2H, J = 5.2 Hz), 3.93 (s, 3H, -OCH3), 4.42 (t, 2H,
J = 5.6 Hz), 6.64–7.14 (m, 4H), 7.40–7.84 (m, 4H),
7.69 (s, 1H) 12.26 (s, 1H); 13C NMR (DMSO-d6): δ
21.5 (-CH3), 54.1 (C-6), 55.9 (-OCH3), 63.1 (C-5),
105.9 (C-5′), 114.8 (C-9 and C-13), 115.3 (C-10 and
C-12), 127.6 (C-8′ and C-12′), 129.9 (C-9′ and C-
11′), 137.8 (C-10′), 130.4 (C-7′), 136.4 (C-8), 150.5
(C-4′), 150.9 (C-2), 152.4 (C-11), 161.6 (C-7), 164.5
(C-2′); LC-MS: 409.2 (M+H)+; Anal. % Calc for
C21H20N4O3S: C: 61.75, H: 4.94, N: 13.79; Found: C:
61.69, H: 4.89, N: 13.72.
2.3j 4-(4-Nitrophenyl)-N-(4-(4-chlorophenyl)-thiazol-
2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide
(7k): Obtained from 6d (2.72 g, 11.00 mmol) and
2b (2.10 g, 10.00 mmol) yield 57% (2.41 g); IR (KBr
cm−1): ν 3119 (-NH), 1698 (-C=O), 3062 (Ar-CH),
1135 (C-O-C), 1589 (Ar-C=C), 724 (C-S), 2350 (Ar-
Cl), 1545 and 1350 (NO2); 1H NMR (DMSO-d6):
δ 3.82 (t, 2H, J = 5.2 Hz), 4.43 (t, 2H, J = 5.6 Hz),
7.32–8.21 (m, 4H), 7.16–7.72 (m, 4H), 7.66 (s, 1H)
12.26 (s, 1H); 13C NMR (DMSO-d6): δ 54.2 (C-6),
63.2 (C-5), 105.9 (C-5′), 114.7 (C-9 and C-13), 124.9
(C-10 and C-12), 129.1 (C-8′ and C-12′), 130.0 (C-9′
and C-11′), 135.1 (C-10′), 131.3 (C-7′), 141.3 (C-11),
150.1 (C-8), 150.5 (C-4′), 150.9 (C-2), 166.3 (C-7),
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164.6 (C-2′); LC-MS: 424.4 (M+H)+; Anal. % Calc
for C19H14ClN5O4S: C: 51.48, H: 3.18, N: 15.78;
Found: C: 51.41, H: 3.15, N: 15.70.
2.3k 4-(4-Nitrophenyl)-N-(4-(p-tolyl)-thiazol-2-yl)-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7l):
Obtained from 6d (2.72 g 11.00 mmol) and 2d (1.90 g
10.00 mmol), yield 58% (2.45 g); IR (KBr cm−1):
ν 3114 (-NH), 1683 (-C=O), 3062 (Ar-CH), 1135
(C-O-C), 1581 (Ar-C=C), 721 (C-S), 2232 (Ar-C),
1545 and 1350 (-NO2); 1H NMR (DMSO-d6): δ 2.36
(s, 3H, CH3), 3.81 (t, 2H, J = 5.2 Hz), 4.43 (t, 2H, J =
5.6 Hz), 7.32–8.21 (m, 4H), 7.40–7.84 (m, 4H), 7.68
(s, 1H), 12.26 (s, 1H); 13C NMR (DMSO-d6): δ 21.5
(-CH3), 54.3 (C-6), 63.1 (C-5), 105.8 (C-5′), 114.7
(C-9 and C-13), 124.9 (C-10 and C-12), 141.3 (C-11),
150.1 (C-8), 127.6 (C-8′ and C-12′), 130.0 (C-9′ and
C-11′), 137.8 (C-10′), 130.44 (C-7′), 150.4 (C-4′),
150.9 (C-2), 161.2 (C-7), 164.5 (C-2′); LC-MS: 424.5
(M+H)+; Anal. % Calc for C20H17N5O4S: C: 56.76,
H: 4.06, N: 16.54; Found: C: 56.70, H: 4.02, N: 16.47.
2.4 Biological studies of 4-Aryl-N-(4-aryl-thiazol-
2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-
carboxamides 7a–l
2.4a Antioxidant studies:
2.4b DPPH radical scavenging assay: Antioxidant
activity of the synthesized 4-aryl-N-(4-aryl-thiazol-2-
yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides
7a-l in comparison to standard antioxidant butylated
hydroxyl toluene (BHT) on DPPH radical was esti-
mated according to the method of Lai et al.25 Samples
7a-l (10, 50 and 100 µg/mL) and BHT (0–5 µg/mL)
were taken in methanol in 200 µL aliquot and mixed
with 100 mM Tris-HCl buffer (800 µL, pH 7.4) and
then 1 mL of 500 µM DPPH was added in ethanol
(final concentration of 250 µM). The mixture was
shaken vigorously and left to settle for 20 min at room
temperature in the dark. Absorbance of the result-
ing solution was measured spectrophotometrically at
517 nm. The capability to scavenge DPPH radical was
calculated using eq. (1).
DPPH Scavenging activity (%)
= [(Acontrol − Asample
)
/Acontrol
] × 100 (1)
2.4c Measurement of reducing power: The reducing
power of synthesized 4-aryl-N-(4-aryl-thiazol-2-yl)-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l
was determined according to the method of Yen and
Chen.26 The samples 7a-l (10, 50 and 100 μg/mL) were
mixed with equal volumes of 0.2 M phosphate buffer
(pH 6.6) and 1% potassium ferricyanide. The mixture
was incubated at 50◦C for 20 min. Then, an equal vol-
ume of 10% trichloroacetic acid was added to the mix-
ture and then centrifuged at 5000 rpm for 10 min.
The upper layer of solution was mixed with distilled
water and 0.1% ferric chloride at a ratio of 1:1:2 and
the absorbance were measured at 700 nm. Increased
absorbance of the reaction mixture indicated increased
reducing power.
2.4d DNA damage inhibition assay: DNA dam-
age inhibition ability of synthesized 4-aryl-N-(4-
aryl-thiazol- 2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-
carboxamides 7a-l was performed using lambda phage
DNA.27,28 Briefly, lambda phage DNA (0.6 μg) was
subjected to oxidation using Fenton’s reagent (0.3 mM
hydrogen peroxide, 0.5 μM ascorbic acid and 0.8 μM
ferric chloride) in presence and absence of the sam-
ple (0.2 mg) for 2 h at 37◦C. The samples 7a-l were
subjected to electrophoresis (Bio-rad Gel electrophore-
sis unit) on 1% agarose for 2 h at 50 volts DC. Gels
were stained with ethidium bromide (0.5 μg/mL) and
documented (Bio-rad gel documentation unit).
2.4e Statistical analysis: All the experiments were
carried out in triplicates (n = 3) and the results
were expressed as mean ± standard deviation
(SD) as shown in table 1. Graphical representa-
tion of DPPH radical scavenging activity of the
synthesized 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-
4H-1,3,4-oxadiazine-2-carboxamides 7a-l is as shown
in figures 1–3. Pictorial representation of DNA damage
inhibition activity is shown in figure 4.
3. Results and Discussion
Derivatives of 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-
2-carboxylic acid 6a-d were obtained from 4-aryl-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylates 5a-d
on treating with 5% NaOH solution using methanol
as a solvent for about 24 h. The obtained com-
pounds 6a-d were soluble in 5% NaHCO3 and re-
precipitated on acidification, which indicated the for-
mation of 4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-
2-carboxylic acid. Structural proof for the compounds
6a-d was confirmed by spectral studies. For instance,
in IR spectra, signal at 1725–1736 cm−1 of >C=O
is shifted to 1680–1695 cm−1 and a signal appeared
at 2733–2745 cm−1 due to -OH group. In 1H NMR
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Table 1. DPPH radical scavenging activity and reducing power of samples 7a–l compared with standard antioxidant BHT.
Compounds % DPPH radical scavenging activity* % Reducing power determination*
10 (μg/mL) 50 (μg/mL) 100 (μg/mL) 10 (μg/mL) 50 (μg/mL) 100 (μg/mL)
7a 16 ± 0.022 28 ± 0.091 51 ± 0.099 06 ± 0.091 12 ± 0.082 56 ± 0.088
7b 18 ± 0.092 33 ± 0.013 55 ± 0.066 07 ± 0.019 22 ± 0.027 62 ± 0.082
7c 24 ± 0.016 41 ± 0.086 76 ± 0.055 11 ± 0.036 34 ± 0.011 79 ± 0.045
7d 23 ± 0.022 42 ± 0.012 67 ± 0.079 08 ± 0.086 22 ± 0.092 65 ± 0.012
7e 29 ± 0.013 39 ± 0.032 69 ± 0.086 12 ± 0.083 28 ± 0.016 68 ± 0.023
7f 27 ± 0.191 56 ± 0.111 76 ± 0.093 13 ± 0.019 29 ± 0.016 69 ± 0.061
7g 23 ± 0.226 40 ± 0.183 68 ± 0.082 10 ± 0.086 26 ± 0.092 62 ± 0.012
7h 29 ± 0.10 53 ± 0.099 82 ± 0.093 14 ± 0.016 32 ± 0.082 82 ± 0.082
7i 25 ± 0.012 42 ± 0.082 44 ± 0.016 07 ± 0.016 27 ± 0.082 64 ± 0.082
7j 18 ± 0.076 28 ± 0.036 39 ± 0.032 08 ± 0.019 16 ± 0.016 58 ± 0.061
7k 15 ± 0.067 29 ± 0.036 41 ± 0.034 06 ± 0.024 15 ± 0.026 57 ± 0.053
7l 17 ± 0.421 27 ± 0.136 38 ± 0.133 05 ± 0.213 17 ± 0.417 56 ± 0.396
(BHT) Standard 32 ± 0.018 57 ± 0.083 94 ± 0.012 16 ± 0.183 32 ± 112 86 ± 0.163
* Values are expressed as mean ± standard deviation (n = 3)
spectra, the absence of quartet in the region δ 4.12–
4.31 ppm, (2H for -OCH2 group) and triplet in the
region δ 1.18–1.30 ppm, (3H for -OCH2-CH3 group)
and the presence of carboxylic acid peak at δ 11.82–
11.85 ppm confirmed the formation of product 6a-
d. In 13C NMR, peak due to -CH3 at δ 13.7–
13.9 ppm and -OCH2 at δ 60.9–61.4 ppm disap-
peared and the peak, due to -C=O shifted to δ
168.1–168.2 ppm from δ 158.4–158.6 ppm. All the
synthesized 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-
carboxylic acids showed (M+H)+ peak which was con-
sistent with the assigned structure in the mass spectra.
The obtained compounds 6a-d were condensed with
2-amino-4-aryl-thiazole derivatives 2a-d to give 4-
aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxa-
diazine-2-carboxamides 7a-l. The obtained samples
7a-l were confirmed by IR, 1H NMR, 13C NMR and
MS studies. The IR spectra shows the amide -NH
Figure 1. DDPH radical scavenging assay of 7a-l.
frequency in the region 3112.4–3120.9 cm−1 and
-C=O frequency region 1670.2–1690.5 cm−1. 1H NMR
spectra shows, the absence of carboxylic acid peak at
δ 11.82–11.85 ppm and the appearance of single small
peak due to -CONH- protons in the region δ 12.24–
12.31 ppm. The peaks of aromatic protons due to
substituted thiazole moiety appear at δ 7.4–8.12 ppm,
and in all the derivatives, one singlet peak of thiazole -
CH- proton appeared at δ 7.65–7.69 ppm. In 13C NMR,
in addition to aromatic carbon peaks at δ 113–154 ppm,
a single peak at δ 105.4–105.9 ppm appeared in all
the derivatives. All the 4-aryl-N-(4-aryl-thiazol-2-yl)-
5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l
showed (M+H)+ peak in the mass spectra. The above
spectral evidence confirms the formation of products.
3.1 Antioxidant activity of samples 7a–l
3.1a DPPH radical scavenging assay: The free radi-
cal scavenging ability of samples 7a-l was evaluated
Figure 2. Bar graph representation of DDPH radical sca-
venging assay of 7a-l.
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Figure 3. Graphical representation of reducing power of
7a-l.
by DPPH scavenging model system using eq. (1). All
the samples 7a-l showed free radical scavenging abil-
ity. The data from table 1 reveals that compounds 7a-
l of synthesized derivatives 7a-l exhibit good DPPH
free radical scavenging activity compared to standard
antioxidant (BHT). These results indicate the potential
electron donating ability of the samples. The DDPH
radical scavenging assays of 7a-l are shown graphically
in figures 1 and 2.
3.1b Reducing ability study of 7a-l: Reducing power
of samples 7a–l was also evaluated (table 1) for
their ability to reduce ferric chloride and potassium
ferricyanide complex. At the initial concentrations
(10 μg/mL), no significant differences in the activ-
ity were observed. However, as the concentration
was increased (50–100 μg/mL), reducing power also
increased. Increased absorbance at 700 nm indicated
the reducing ability of the synthesized compounds. The
enhanced reducing power of 7h and 7c may be due to
the presence of electron donating groups at para posi-
tion of the phenyl ring. Graphical representation of
reducing power is shown in figure 3.
3.1c DNA damage inhibition studies: DNA damage
inhibition ability of samples 7a-l was evaluated on
lambda phage DNA oxidation. The hydroxyl radical
generated by Fenton’s reagent caused DNA fragmen-
tation with increase in its electrophoresis mobility and
thereby the fragments had run out of the gel (lane
2). Treatment of samples 7a-l prior to oxidation min-
imized the extent of DNA damage. As evidenced by
gel documentation analysis, compared to negative DNA
(figure 4), out of all the samples compounds having
electron donating groups at para-position of the aryl
group, 7e, 7h, 7c and 7f, showed better DNA damage
Figure 4. Electrophoretic mobility of DNA in treated
samples.
inhibition. Electrophoretic mobility of DNA is shown
in figure 4.
4. Conclusions
We have synthesized a new series of compounds 7a–
l and evaluated them for their DNA damage inhibi-
tion and antioxidant activities. Compounds 7e, 7h, 7c
and 7f having electron donating groups at para position
of aryl moiety demonstrated potent antioxidant activ-
ity and DNA damage inhibition compared to the stan-
dard. These compounds might be blocking the process
of oxidation by neutralizing free radicals via interaction
of the lone pair of electrons (on -Cl, -OCH3 and -OH)
with DPPH radical.
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